Clinical trial

Immune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During Pregnancy

NCT07149662

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention monoclonal CD-20 antibodies Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention No Drug Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Other treatment Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Immune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During Pregnancy

Design: OBSERVATIONAL · Status: NOT YET RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2026-02-01

PhaseN/A

Conditions

Multiple Sclerosisverified · MONDO: multiple sclerosis

Pregnancyunresolved

Interventions

monoclonal CD-20 antibodiesDRUG

No DrugDRUG

Other treatmentDRUG

Sponsors & collaborators

Region Stockholmlead sponsor

The Swedish Research Councilcollaborator

Haukeland University Hospitalcollaborator

Karolinska Institutetcollaborator

Mapped research locations

StockholmSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07149662 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.